GAITHERSBURG, Md., July 09, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based…
All-in-one, intelligent healthcare platform empowers patients and clinicians with instant insights, tailored support, and streamlined care. DENVER, July 8, 2025…
All-in-one, intelligent healthcare platform empowers patients and clinicians with instant insights, tailored support, and streamlined care. DENVER, July 8, 2025…
Independent Audit Confirms Medsender's Platform Meets Rigorous Data Security and Operational Controls NEW YORK, July 8, 2025 /PRNewswire/ -- Medsender®,…
Paragon® Denali, TouchWorks® EHR and dbMotion™ Solution users to gain access to more patient records, supporting improved patient outcomes and…
AI-powered tools help doctors and nurses save time and keep patients informed and on track with their medications EDISON, N.J.…
Timely texts and pharmacy savings drive better adherence, affordability, and outcomes. ANNAPOLIS, Md. and BOSTON, July 8, 2025 /PRNewswire/ --…
WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”),…
A new category of plant-based formulations is gaining attention for their role in supporting internal balance and inflammation-linked metabolic concerns.…
Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries…